United Therapeutics Corp
XMUN:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
P
|
PharmaSGP Holding SE
F:PSG
|
DE |
|
E
|
Evertec Inc
SWB:2EV
|
PR |
|
P
|
Persimmon PLC
F:OHP
|
UK |
|
D
|
Dai-ichi Life Holdings Inc
XMUN:QHH
|
JP |
Wall St Price Targets
UTH Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for UTH is 526.72 EUR with a low forecast of 399.06 EUR and a high forecast of 645.65 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTH's stock price target?
Price Target
526.72
EUR
According to Wall Street analysts, the average 1-year price target for UTH is 526.72 EUR with a low forecast of 399.06 EUR and a high forecast of 645.65 EUR.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 9%.
